Personalis, Inc.
PSNL
$9.75
-$0.29-2.89%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/8/2026
-
MarketBeat
6/9/2026
-
Simply Wall St
6/9/2026
-
TipRanks: TheFly
6/9/2026
-
Business Wire
6/9/2026
-
Tickeron - Stocks
6/7/2026
-
Simply Wall St
6/7/2026
-
Tickeron - Stocks
6/4/2026
-
The Cerbat Gem
6/4/2026
-
Nasdaq News: Markets
6/4/2026
-
Fool.com Headlines
6/2/2026
-
Business Wire
6/1/2026
-
Simply Wall St
5/31/2026
-
The Cerbat Gem
5/30/2026
-
The Cerbat Gem
5/29/2026
-
Simply Wall St
5/29/2026
-
Tickeron - Stocks
5/28/2026
-
Seeking Alpha - Long Ideas
5/28/2026
-
SeekingAlpha
5/28/2026
-
Market News Video
5/28/2026
-
Nasdaq News: ETFs
5/26/2026
-
Business Wire
5/21/2026
-
TipRanks Financial Blog
5/20/2026
-
Benzinga
5/20/2026
-
Seeking Alpha - Healthcare
5/20/2026
-
The Cerbat Gem
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 752 1300
Address
6600 Dumbarton Circle
Fremont, CA 94555
Fremont, CA 94555
Country
Year Founded
Business Description
Sector
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy...
more